# 11 - References

# References

Schizophrenia and related psychoses
CHAPTER 1
References
1. Electronic Medicines Compendium. Summaries of Product Characteristics. (Last accessed January 2025); https://www.medicines.org.uk/emc.
2. US Food and Drug Administration. Highlights of Prescribing Information. 2024; https://www.fda.gov/drugs.
3. Inoue Y, et al. Safety and effectiveness of oral blonanserin for schizophrenia: a review of Japanese post-­marketing surveillances. J Pharmacolog 
Sci 2021; 145:42–51.
4. Nishibe H, et al. Striatal dopamine D2 receptor occupancy induced by daily application of blonanserin transdermal patches: phase 2 study in 
Japanese patients with schizophrenia. Int J Neuropsychopharmacol 2021; 24:108–117.